10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q2 2024

Filing Information

Form Type	10-Q
Accession Number	`0000950170-24-092713`
Period End Date	20240630
Filing Date	20240807
Fiscal Year	2024
Fiscal Period	Q2
XBRL Instance	slno-20240630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 146 Income Statement 136 Cash Flow Statement 136 Stockholders Equity 78

Balance Sheet 146 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.68M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.68M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	38.39M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	38.39M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	38.39M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	38.39M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$169.68M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.68M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.68M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.02M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$57.02M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$209.10M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$209.10M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.38M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.38M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.68M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$267.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$267.50M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$171.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$171.36M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$19.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$19.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$268.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$268.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$407.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$407.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.78M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$7.78M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.75M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$8.75M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$28.48M	USD	Point-in-time
Long-term marketable securities	`MarketableSecuritiesNoncurrent`	$28.48M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$83.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$165.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$165.00K	USD	Point-in-time
Total assets	`Assets`	$180.69M	USD	Point-in-time
Total assets	`Assets`	$180.69M	USD	Point-in-time
Total assets	`Assets`	$304.13M	USD	Point-in-time
Total assets	`Assets`	$304.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.15M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.72M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.72M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$2.15M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$2.15M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.13M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$3.13M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$3.39M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$3.39M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.86M	USD	Point-in-time
Accrued clinical trial site costs	`AccruedClinicalTrialCostsCurrent`	$1.86M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$296.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$296.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$273.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$273.00K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.55M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.13M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.13M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.15M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.15M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$11.51M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$13.59M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$13.59M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$11.55M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`AssetAcquisitionContingentConsiderationLiabilityNoncurrent`	$11.55M	USD	Point-in-time
Common stock purchase liability	`CommonStockPurchaseLiabilityNonCurrent`	$637.00K	USD	Point-in-time
Common stock purchase liability	`CommonStockPurchaseLiabilityNonCurrent`	$637.00K	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$130.00K	USD	Point-in-time
Long-term lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$130.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$23.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$23.18M	USD	Point-in-time
Total liabilities	`Liabilities`	$23.37M	USD	Point-in-time
Total liabilities	`Liabilities`	$23.37M	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 6)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 10,000,000 shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 38,386,779 and 31,678,159 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$38.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 38,386,779 and 31,678,159 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$38.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 38,386,779 and 31,678,159 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 38,386,779 and 31,678,159 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively	`CommonStockValue`	$32.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$433.88M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$433.88M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$600.53M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$600.53M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-153.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-153.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	-	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-319.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-319.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-276.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-276.41M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$12.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$12.43M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$157.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$143.39M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.35M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$10.35M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$280.76M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.64M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$2.64M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$304.13M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$304.13M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$180.69M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$180.69M	USD	Point-in-time

Income Statement 136 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$26.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$26.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$12.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$12.34M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.14M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$5.14M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$10.46M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$10.46M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$19.36M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$19.36M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$10.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$10.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$6.02M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.02M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.17M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.17M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$612.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$612.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$313.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$313.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$8.62M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$8.62M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$17.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$17.09M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$48.34M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$48.34M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$24.87M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$24.87M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-8.62M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-8.62M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-24.87M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-24.87M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-17.09M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-17.09M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-48.34M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-48.34M	USD	2 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	2 Qtrs
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$5.09M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$5.09M	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$260.00K	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$260.00K	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$147.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$147.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.01M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$3.01M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$148.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$148.00K	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$261.00K	USD	2 Qtrs
Total other income, net	`NonoperatingIncomeExpense`	$261.00K	USD	2 Qtrs
Total other income, net	`NonoperatingIncomeExpense`	$3.01M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$3.01M	USD	1 Quarter
Total other income, net	`NonoperatingIncomeExpense`	$5.09M	USD	2 Qtrs
Total other income, net	`NonoperatingIncomeExpense`	$5.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	2 Qtrs
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	-	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-46.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-46.00K	USD	1 Quarter
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-151.00K	USD	2 Qtrs
Net unrealized loss on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-151.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.90M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-21.90M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.83M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.83M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.41M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-43.41M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.49M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.49M	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-1.16	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-1.16	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-0.81	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.81	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-1.69	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-1.69	USD	2 Qtrs
Net loss per common share basic	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Net loss per common share basic	`EarningsPerShareBasic`	$-0.57	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.81	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.81	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.69	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.69	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-0.57	USD	1 Quarter
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.16	USD	2 Qtrs
Net loss per common share diluted	`EarningsPerShareDiluted`	$-1.16	USD	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	10.42M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	10.42M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	9.94M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	9.94M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic net loss per common share	`WeightedAverageNumberOfSharesOutstandingBasic`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	38.63M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.94M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.94M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	37.42M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.42M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate diluted net loss per common share	`WeightedAverageNumberOfDilutedSharesOutstanding`	10.42M	shares	1 Quarter

Cash Flow Statement 136 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-16.83M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-16.83M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-43.25M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-43.25M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$979.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$979.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$984.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$984.00K	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.59M	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.59M	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	2 Qtrs
Accretion of premium/discount on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	-	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$187.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$187.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$139.00K	USD	2 Qtrs
Non-cash lease expense	`NoncashLeaseExpense`	$139.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.83M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.83M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$13.61M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$13.61M	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	1 Quarter
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	2 Qtrs
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-1.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$1.64M	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$612.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$612.00K	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$313.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$313.00K	USD	1 Quarter
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Change in fair value of contingent consideration	`AssetAcquisitionContingentConsiderationChangeInFairValue`	$2.04M	USD	2 Qtrs
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	-	USD	2 Qtrs
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	-	USD	2 Qtrs
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$-2.00K	USD	2 Qtrs
Other non-cash reconciling items	`OtherOperatingActivitiesCashFlowStatement`	$-2.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-380.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-380.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$290.00K	USD	2 Qtrs
Prepaid expenses, other current assets and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$290.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$567.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$567.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.68M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.68M	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-510.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-510.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-986.00K	USD	2 Qtrs
Accrued compensation	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-986.00K	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-1.53M	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$-1.53M	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$244.00K	USD	2 Qtrs
Accrued clinical trial site costs	`IncreaseDecreaseInAccruedClinicalTrialSiteCosts`	$244.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-107.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-107.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-227.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-227.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-429.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-429.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$29.00K	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$29.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.18M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-30.18M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.29M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.29M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$261.15M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$261.15M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$25.00M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$25.00M	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-236.16M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-236.16M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from the sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$148.96M	USD	2 Qtrs
Proceeds from the sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$148.96M	USD	2 Qtrs
Proceeds from the sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$7.10M	USD	2 Qtrs
Proceeds from the sale of common stock, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$7.10M	USD	2 Qtrs
Proceeds received prior to and for the issuance of common stock	`ProceedsReceivedPriorToAndForTheIssuanceOfCommonStock`	$637.00K	USD	2 Qtrs
Proceeds received prior to and for the issuance of common stock	`ProceedsReceivedPriorToAndForTheIssuanceOfCommonStock`	$637.00K	USD	2 Qtrs
Proceeds received prior to and for the issuance of common stock	`ProceedsReceivedPriorToAndForTheIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds received prior to and for the issuance of common stock	`ProceedsReceivedPriorToAndForTheIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the sale of common stock and common stock warrants, net of costs	`ProceedsFromSaleOfCommonStockAndCommonStockWarrantsNetOfIssuanceCosts`	-	USD	2 Qtrs
Proceeds from the sale of common stock and common stock warrants, net of costs	`ProceedsFromSaleOfCommonStockAndCommonStockWarrantsNetOfIssuanceCosts`	-	USD	2 Qtrs
Proceeds from the sale of common stock and common stock warrants, net of costs	`ProceedsFromSaleOfCommonStockAndCommonStockWarrantsNetOfIssuanceCosts`	$9.96M	USD	2 Qtrs
Proceeds from the sale of common stock and common stock warrants, net of costs	`ProceedsFromSaleOfCommonStockAndCommonStockWarrantsNetOfIssuanceCosts`	$9.96M	USD	2 Qtrs
Proceeds from exercise of common stock and pre-funded stock warrants	`ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants`	$3.54M	USD	2 Qtrs
Proceeds from exercise of common stock and pre-funded stock warrants	`ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants`	$3.54M	USD	2 Qtrs
Proceeds from exercise of common stock and pre-funded stock warrants	`ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants`	-	USD	2 Qtrs
Proceeds from exercise of common stock and pre-funded stock warrants	`ProceedsFromExerciseOfCommonStockAndPreFundedStockWarrants`	-	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$552.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$552.00K	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$153.69M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$153.69M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.06M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.06M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-112.66M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-112.66M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.77M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.77M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.37M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.37M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$14.60M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.37M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.37M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$57.02M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$169.68M	USD	Point-in-time
Operating lease right-of-use assets obtained in exchange for operating lease obligations	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$597.00K	USD	2 Qtrs
Operating lease right-of-use assets obtained in exchange for operating lease obligations	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$597.00K	USD	2 Qtrs
Operating lease right-of-use assets obtained in exchange for operating lease obligations	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Operating lease right-of-use assets obtained in exchange for operating lease obligations	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	-	USD	2 Qtrs
Unpaid financing costs included in accounts payable	`UnpaidCostsForIssuingCommonStockAndPreFundedWarrants`	$14.00K	USD	2 Qtrs
Unpaid financing costs included in accounts payable	`UnpaidCostsForIssuingCommonStockAndPreFundedWarrants`	$14.00K	USD	2 Qtrs
Unpaid financing costs included in accounts payable	`UnpaidCostsForIssuingCommonStockAndPreFundedWarrants`	-	USD	2 Qtrs
Unpaid financing costs included in accounts payable	`UnpaidCostsForIssuingCommonStockAndPreFundedWarrants`	-	USD	2 Qtrs

Stockholders Equity 78 line items

Line Item	Tag	Value	Unit	Period
Less transaction costs	`PaymentsOfStockIssuanceCosts`	$9.75M	USD	1 Quarter
Less transaction costs	`PaymentsOfStockIssuanceCosts`	$9.75M	USD	1 Quarter
Balances at beginning	`StockholdersEquity`	$12.43M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$12.43M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$2.64M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$2.64M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.16M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.16M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$495.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$495.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$6.45M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.20M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.20M	USD	1 Quarter
Issuance of restricted stock units under equity incentive plans	`IssuanceOfRestrictedStockUnitsValueAndOptionExercisesUnderEquityIncentivePlan`	$136.00K	USD	1 Quarter
Issuance of restricted stock units under equity incentive plans	`IssuanceOfRestrictedStockUnitsValueAndOptionExercisesUnderEquityIncentivePlan`	$136.00K	USD	1 Quarter
Issuance of common stock warrants, net of issuance costs	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$9.97M	USD	1 Quarter
Issuance of common stock warrants, net of issuance costs	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$9.97M	USD	1 Quarter
Sale of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$7.10M	USD	1 Quarter
Sale of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$7.10M	USD	1 Quarter
Sale of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$148.96M	USD	1 Quarter
Sale of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$148.96M	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$923.00K	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$2.62M	USD	1 Quarter
Exercise of common stock warrants and pre-funded common stock warrants	`StockIssuedDuringPeriodValueExerciseOfCommonStockWarrantsAndPreFundedCommonStockWarrants`	$2.62M	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-15.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-15.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-537.00K	USD	1 Quarter
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$-537.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-46.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-46.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Unrealized loss on marketable securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-105.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-2.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-16.83M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.36M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.47M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-43.25M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-21.40M	USD	1 Quarter
Balances at ending	`StockholdersEquity`	$12.43M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$12.43M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$157.51M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$143.39M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$10.35M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$280.76M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$2.64M	USD	Point-in-time
Balances at ending	`StockholdersEquity`	$2.64M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.